CUSIP 640979100COMNMRAQ4 2025
15 filings · latest Feb 19, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Softbank Group Corp. | 6.43M | $11.51M |
| 2 | Siren, L.L.C. | 6.29M | $11.26M |
| 3 | Vanguard Group Inc | 4.54M | $8.13M |
| 4 | Mic Capital Management Uk LLP | 4.46M | $7.98M |
| 5 | Point72 Asset Management, L.P. | 3.67M | $6.58M |
| 6 | Millennium Management LLC | 3.62M | $6.47M |
| 7 | Fmr LLC | 3.50M | $6.26M |
| 8 | Wellcome Trust Ltd (The) As Trustee Of The Wellcome Trust | 3.31M | $5.92M |
| 9 |
| 4 | Aug 11, 2025 | K2 Healthventures Equity Trust LLC | 13G | 6.6% | 92.03T | SEC |
| 5 | May 12, 2025 | Fmr LLC | 13G/A | 2.2% | 3.50M | SEC |
| 6 | Feb 13, 2025 | Paul L Berns | 13G/A | 5.1% | 8.23M | SEC |
| 7 | Nov 22, 2024 | Arch Venture Fund Xii, L.P. | 13D/A | 19.8% | 31.93M | SEC |
| 8 | Nov 12, 2024 | Softbank Group Corp. | 13G | 4.7% | 7.55M | SEC |
| 9 | Jul 8, 2024 | Fmr LLC | 13G | 5.4% | 8.62M | SEC |
| 10 | Jul 8, 2024 | Fmr LLC | 13G | 5.4% | 8.62M | SEC |
See the full Schedule 13D/13G history for Neumora Therapeutics Inc..
Unlock full history| Iconiq Capital, LLC |
| 2.56M |
| $4.58M |
| 10 | Lunate Capital Ltd | 2.12M | $3.80M |